HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Leuthold Group LLC

Leuthold Group LLC boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.0% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 19,920 shares of the company’s stock after acquiring an additional 1,648 shares during the period. Leuthold Group LLC’s holdings in HCA Healthcare were worth $6,400,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in HCA. Royal Bank of Canada raised its holdings in shares of HCA Healthcare by 35.7% during the 4th quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock worth $1,219,121,000 after acquiring an additional 1,183,890 shares during the period. Capital World Investors grew its holdings in shares of HCA Healthcare by 57.5% during the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after purchasing an additional 1,019,750 shares during the period. Sanders Capital LLC boosted its stake in HCA Healthcare by 4.2% during the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after buying an additional 456,738 shares during the period. Lee Danner & Bass Inc. purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $131,527,000. Finally, TD Asset Management Inc boosted its position in shares of HCA Healthcare by 230.5% during the 4th quarter. TD Asset Management Inc now owns 553,225 shares of the company’s stock worth $149,747,000 after purchasing an additional 385,854 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Price Performance

HCA opened at $399.89 on Thursday. The company has a 50 day moving average of $367.24 and a two-hundred day moving average of $339.56. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $404.90. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The company has a market cap of $104.74 billion, a P/E ratio of 19.93, a P/E/G ratio of 1.46 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $4.29 earnings per share. On average, analysts expect that HCA Healthcare, Inc. will post 22.46 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.66%. HCA Healthcare’s payout ratio is currently 13.16%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on HCA shares. Morgan Stanley initiated coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target on the stock. Barclays increased their price objective on HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a report on Wednesday, July 24th. Baird R W upgraded shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Robert W. Baird began coverage on shares of HCA Healthcare in a report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 target price for the company. Finally, Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Five investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have given a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $359.89.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.